EFG Asset Management (Americas)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
EFG Asset Management (Americas)'s EW Position: Q4 2022 in Review
EFG Asset Management (Americas) sold out of Edwards Lifesciences (EW) in Q4 2022, closing a stake of 3,693 shares — an estimated $305K sold.
EFG Asset Management (Americas) first reported a position in EW in Q2 2017 and held it in 12 quarters. The position peaked at $638K in Q4 2021. 1,229 funds tracked by Wall St. Rank hold EW as of Q4 2022.
- EFG Asset Management (Americas) reported no remaining Edwards Lifesciences position as of Q4 2022 after selling out during the quarter.
- EFG Asset Management (Americas) sold 3,693 Edwards Lifesciences shares in Q4 2022, an estimated $305K.
- EFG Asset Management (Americas) first reported a position in Edwards Lifesciences in Q2 2017 and held it in 12 quarters.
- EFG Asset Management (Americas)'s Edwards Lifesciences position peaked at $638K in Q4 2021.
- 1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.
Based on EFG Asset Management (Americas)'s 13F filing for Q4 2022, filed 9 Feb 2023.